Activate Now
 
ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Ten Tips to Simplify, Lower the Cost, and Optimize CFS and fibromyalgia Treatment

Patient Insights into the Design of Technology to Support a Strengths-Based Approach to Health Care.

Keep Learning – Even From Bed!

Iron Man: A Young Person's POTS ME/CFS Recovery Story Pt. I

Why You Should Make Your Pleasure a Top Priority

Researchers Identify Characteristic Chemical Signature for Chronic Fatigue Syndrome

SURVEY: Weight Management & Chronic Illness

The NIH’s Big Change: Is it Coming For Chronic Fatigue Syndrome (ME/CFS)?

Metabolic features of chronic fatigue syndrome

VIDEO: September is Pain Awareness Month

 
Print Page
Email Article

K-PAX Pharmaceuticals and Stanford University to Collaborate on Clinical Trial to Study New Treatment for Chronic Fatigue Syndrome

  [ 11 votes ]   [ 1 Comment ]
www.ProHealth.com • March 5, 2014


K-PAX Pharmaceuticals and Stanford University to Collaborate on Clinical Trial to Study New Treatment for Chronic Fatigue Syndrome
MILL VALLEY, Calif., Feb. 26, 2014 /PRNewswire/ -- K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.

The Synergy Trial (http://thesynergytrial.org) will enroll 120 subjects at four research sites throughout the United States. It is the largest double-blind, placebo-controlled pharmaceutical intervention trial in people with CFS to date. In addition to Stanford University, the other research sites include Salt Lake City, New York City, and Nova Southeastern University in Fort Lauderdale, Florida.

This randomized clinical trial will test a combination of a low-dose CNS stimulant (methylphenidate - a generic version of Ritalin®) co-administered with a CFS mitochondrial support formula. This nutrient formula is a broad-spectrum micronutrient supplement designed to provide therapeutic dosages of key nutrients that support the functioning of the nervous, endocrine, and immune systems to a level at which concomitantly administered methylphenidate can produce a positive effect on CFS symptoms.

When this treatment was previously administered to 15 prospectively recruited patients as innovative therapy, it produced encouraging results resulting in a significant improvement in both fatigue and concentration disturbance symptoms (i.e. brain fog) as measured by the Checklist Individual Strength (CIS), a validated research tool used to assess fatigue in patients with Chronic Fatigue Syndrome. This improvement occurred in greater than 50% of the CFS patients after just 12 weeks.  Based upon these results, K-PAX Pharmaceuticals is pursuing further investigation of this potentially promising therapy.

Chronic Fatigue Syndrome (CFS) is a debilitating disease that currently affects over 2 million Americans and has no FDA-approved treatments. The FDA has identified CFS as "a serious unmet medical need" and specifically requested that pharmaceutical companies search for a safe and effective treatment.

K-PAX Pharmaceuticals, based in Mill Valley, California, is a privately-held biotechnology company pioneering medicines to strengthen immune function and support optimal energy metabolism. Learn more here.
 



Post a Comment

Featured Products From the ProHealth Store
B-12 Extreme™ MitoQ® Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments Post a Comment

Synergy Trial
Posted by: me/cfs
Mar 6, 2014
This appears to be a promising avenue to the first FDA approval for ME/CFS treatment.

They had promising preliminary results, it is a large multi-site study being carried out by leading ME/CFS researchers and it is an attempt to address concerns with immune, endocrine, and mitochondrial function.

My question to K-PAX would be, have they tried their micronutrients with other pharmaceuticals (besides methylphenidate)? One that I would be curious about would be an antihistamine known as hydroxyzine.

Best hopes for all involved.
Reply Reply
 
Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 Your Brain Needs for Detox & Sharpness
MitoQ® MitoQ®
Powerful Antioxidant Support to Mitochondria

Natural Remedies

Complete and Natural Menopause Relief Complete and Natural Menopause Relief
Herbal Rescue for High Blood Sugar Herbal Rescue for High Blood Sugar
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map